Article

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37

2021-07-23

Abstract excerpt

Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed. 1 However, the emergence of viral variants that are more infectious than the earlier SARS-CoV-2 strains is concerning. 2 Several of these viral variants have the potential to partially escape neutralizing antibody responses warranting continued immune-monitoring. Here, we tested a number of current...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 88c36697-4e5b-5be2-8026-cb349b569e4b
DOI: 10.1101/2021.07.21.21260961

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37DOI 10.1101/2021.07.21.21260961Read

SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodiesSemantic proximity Read

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.Semantic proximity Read

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity.Semantic proximity Read

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.Semantic proximity Read

COVID-19 mRNA vaccine induced antibody responses and neutralizing antibodies against three SARS-CoV-2 variantsSemantic proximity Read

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccinationSemantic proximity Read

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 VariantsSemantic proximity Read

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsSemantic proximity Read

Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolateSemantic proximity Read

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.Semantic proximity Read

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsSemantic proximity Read